Volume 26, Number 3—March 2020
Synopsis
Mycobacterium tuberculosis Complex Lineage 3 as Causative Agent of Pulmonary Tuberculosis, Eastern Sudan1
Table 2
Variable | Year of sample collection, no. (%) isolates |
Total no. | p value | |
---|---|---|---|---|
2014 | 2016 | |||
Lineage | 0.068 | |||
L3 | 51 (82.3) | 71 (68.3) | 122 | |
Non-L3 |
11 (17.7) |
33 (31.7) |
44 |
|
DST | 0.019 | |||
Any drug resistance | 20 (32.3) | 16 (15.4) | 36 | |
No drug resistance |
42 (67.7) |
88 (84.6) |
120 |
|
<12 SNP cluster | 0.016 | |||
Clustered | 36 (58.1) | 40 (38.5) | 76 | |
Not clustered |
26 (41.9) |
64 (61.5) |
90 |
|
All patients | 62 (100) | 104 (100) | 166 |
*DST, drug susceptibility testing; L, lineage; SNP, single-nucleotide polymorphism.
1Preliminary results from this study were presented at the 39th Annual Congress of the European Society of Mycobacteriology, July 1–4, 2018, Dresden, Germany.
2These authors contributed equally to this article.
Page created: February 20, 2020
Page updated: February 20, 2020
Page reviewed: February 20, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.